Last Updated on September 5, 2021 by The Health Master
Dr Reddy’s Laboratories yesterday launched Reddy-Lenalidomide, a generic equivalent to Revlimid (lenalidomide) capsules in the Canadian market.
The product is approved by Health Canada, the company notified in a statement.
Speaking in this regard, Vinod Ramachandran, PhD, Vice President and General Manager, Dr Reddy’s Laboratories Canada, said, “Our launch of Reddy-Lenalidomide represents our firm commitment to providing access to affordable medicines for Canada’s Multiple Myeloma and Myelodysplastic Syndrome (MDS) patient population.”
He also said, “Along with this important launch, we are pleased to introduce our Reddy2Assist Platform, which provides convenient one-stop access to assist prescribers and pharmacists with qualification requirements for patients, as well as patient onboarding and registration via web portal, telephone or fax.”
Reddy-Lenalidomide capsules are available in 2.5 mg, 5 mg, 10 mg, 15 mg, 20 mg, and 25 mg strengths, each in blister packs, the statement said.
Lupin launches drug for Asthma patient
Merck launches Pergoveris Pen for Infertility treatment in India
Alkem launches Ibuprofen, Famotidine tablets
Zydus Cadila gets final nod from USFDA for Fulvestrant injection
USFDA inspection ends with ‘Zero’ observations: Alkem
Granules Pharma clears USFDA audit
DCGI asks State FDAs to restrict Tolperisone FDC for these usage…
Govt to include ICD as depot to import Drugs under Drugs…
NLEM: New list of Essential Medicines: 39 new drugs added, 16…
Granules India gets license from DRDO for Covid drug 2-DG
Pharma Industry urges Govt to include Chile under PLI scheme
Latest Notifications regarding Pharmaceuticals
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
